• 2069 Citations
  • 26 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chul Won Choi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Leucovorin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 2069 Citations
  • 26 h-Index
  • 115 Article
  • 3 Letter
  • 2 Comment/debate
  • 1 Review article
1 Citation (Scopus)

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

Korean Multiple Myeloma Working Party, 2019 Jan 1, In : Japanese Journal of Clinical Oncology. 49, 1, p. 92-95 4 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Emergencies
Respiratory Tract Infections
Disease-Free Survival
Back Pain

Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System

Jung, K. S., Kim, Y. J., Kim, Y. K., Park, S. K., Kim, H. G., Kim, S. J., Park, J., Choi, C. W., Do, Y. R., Kim, I., Park, S., Mun, Y. C., Jeong, S. H., Kim, M. K., Yi, H. G., Chang, M. H., Kim, S. Y., Lee, J. H. & Jang, J. H., 2019 Jan 1, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

decitabine
Myelodysplastic Syndromes
Survival
Observational Studies
1 Citation (Scopus)

Hereditary platelet function disorder from RASGRP2 gene mutations encoding CalDAG-GEFI identified by whole-exome sequencing in a Korean woman with severe bleeding

Yun, J. W., Lee, K. O., Jung, C. W., Oh, S. Y., Kim, S. H., Choi, C. W. & Kim, H. J., 2019 Jan 1, In : Haematologica. 104, 6, p. e274-e276

Research output: Contribution to journalComment/debate

Exome
Blood Platelets
Hemorrhage
Mutation
Genes

Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

The Korean Society of Haematology AML/MDS Working Party, 2019 Jan 1, In : British Journal of Haematology.

Research output: Contribution to journalLetter

Open Access
Myelodysplastic Syndromes
Proxy
Therapeutics
lenalidomide

Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma

Park, Y., Kim, D. S., Jeon, M. J., Lee, B. H., Yu, E. S., Kang, K. W., Lee, S. R., Sung, H. J., Nam, M-H., Yoon, S-Y., Choi, C. W., Kang, E. S., Cho, D., Kim, K., Kim, B. S., Kim, D. W. & Kim, S. J., 2019 Jan 1, In : Journal of Clinical Apheresis.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Etoposide
Multiple Myeloma
Stem Cell Transplantation
Blood Component Removal